Skip to content

Achieve Life Sciences ACHV Other income, net (Note 6)

Other income, net (Note 6) at other companies

Pfizer logo
PfizerPFE

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's other income, net (note 6)?
Achieve Life Sciences (ACHV) reported other income, net (note 6) of -$13K in Q1 2026.
How has Achieve Life Sciences's other income, net (note 6) changed year-over-year?
Achieve Life Sciences's other income, net (note 6) decreased by 161.9% year-over-year, from $21K to -$13K.
What is the long-term trend for Achieve Life Sciences's other income, net (note 6)?
Over 2 years (2021 to 2024), Achieve Life Sciences's other income, net (note 6) has grown at a -36.8% compound annual growth rate (CAGR), from -$75K to -$30K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.